Published in Eur Heart J on October 09, 2012
The urea decomposition product cyanate promotes endothelial dysfunction. Kidney Int (2014) 2.81
Platelet function tests: why they fail to guide personalized antithrombotic medication. J Am Heart Assoc (2015) 0.81
Inhibition of Thrombin-Activated Fibrinolysis Inhibitor Increases Survival in Experimental Kidney Fibrosis. J Am Soc Nephrol (2014) 0.76
Angiotensin Receptor Blockers Decrease the Risk of Major Adverse Cardiovascular Events in Patients with End-Stage Renal Disease on Maintenance Dialysis: A Nationwide Matched-Cohort Study. PLoS One (2015) 0.75
Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression. Sci Rep (2016) 0.75
Choosing not to dialyse: evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure. Nephron Clin Pract (2003) 2.96
Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol Dial Transplant (2010) 2.67
Kt/V underestimates the hemodialysis dose in women and small men. Kidney Int (2008) 2.34
An association between depressive symptoms and survival in incident dialysis patients. Nephrol Dial Transplant (2010) 2.23
Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant (2010) 2.00
Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant (2009) 1.99
The ESHOL study: hemodiafiltration improves survival-but how? Kidney Int (2013) 1.98
Quality of life and survival in patients with advanced kidney failure managed conservatively or by dialysis. Clin J Am Soc Nephrol (2012) 1.98
The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant (2009) 1.58
Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction. J Am Coll Cardiol (2010) 1.56
Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy. Nat Clin Pract Nephrol (2008) 1.52
Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol (2010) 1.51
Measuring the quality of end of life management in patients with advanced kidney disease: results from the pan-Thames renal audit group. Nephrol Dial Transplant (2011) 1.49
Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology (2012) 1.46
Comparison of B-type natriuretic peptide and NT proBNP as predictors of survival in patients on high-flux hemodialysis and hemodiafiltration. Hemodial Int (2011) 1.45
The haemodynamic response to submaximal exercise during isovolaemic haemodialysis. Nephrol Dial Transplant (2004) 1.38
Simulation model of renal replacement therapy: predicting future demand in England. Nephrol Dial Transplant (2004) 1.34
Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol (2009) 1.27
The GuideLiner "child" catheter for percutaneous coronary intervention - early clinical experience. J Invasive Cardiol (2010) 1.19
Emerging importance of residual renal function in end-stage renal failure. Semin Dial (2011) 1.19
Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy. Radiology (2011) 1.12
Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study. Nephron Clin Pract (2008) 1.12
Depression on dialysis. Nephron Clin Pract (2008) 1.09
Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int (2002) 1.07
Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? Eur J Radiol (2012) 1.03
Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int (2002) 1.02
Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Blood Purif (2007) 1.01
Cardioprotection initiated by reactive oxygen species is dependent on activation of PKCepsilon. Am J Physiol Heart Circ Physiol (2006) 0.97
Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements. Nat Rev Cardiol (2009) 0.97
Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy. Radiology (2013) 0.96
Erythropoietic stress and anemia in diabetes mellitus. Nat Rev Endocrinol (2009) 0.96
Outcome in glomerulonephritis due to systemic small vessel vasculitis: effect of functional status and non-vasculitic co-morbidity. Nephrol Dial Transplant (2004) 0.96
Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis. J Neurooncol (2011) 0.96
Use of thrombectomy devices in primary percutaneous coronary intervention: a systematic review and meta-analysis. Int J Cardiol (2011) 0.96
Natriuretic peptides and the dialysis patient. Semin Dial (2005) 0.96
Combination ibandronate and radiotherapy for the treatment of bone metastases: clinical evaluation and radiologic assessment. Int J Radiat Oncol Biol Phys (2006) 0.95
Customised broadband metamaterial absorbers for arbitrary polarisation. Opt Express (2010) 0.95
Residual renal function: considerations on its importance and preservation in dialysis patients. Semin Dial (2004) 0.94
Dialysis dose in acute kidney injury and chronic dialysis. Lancet (2010) 0.94
Analytical quality goals for parathyroid hormone based on biological variation. Clin Chem Lab Med (2008) 0.93
Illness perceptions predict survival in haemodialysis patients. Am J Nephrol (2011) 0.93
Illness representations are associated with fluid nonadherence among hemodialysis patients. J Psychosom Res (2009) 0.91
Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J Antimicrob Chemother (2003) 0.91
Nonadherence in dialysis patients: prevalence, measurement, outcome, and psychological determinants. Semin Dial (2013) 0.91
Serial determinations of absolute plasma volume with indocyanine green during hemodialysis. J Am Soc Nephrol (2003) 0.91
Screening for depression while patients dialyse: an evaluation. Nephrol Dial Transplant (2008) 0.90
Factors affecting long-term survival of tunnelled haemodialysis catheters--a prospective audit of 812 tunnelled catheters. Nephrol Dial Transplant (2007) 0.90
Supportive care in advanced kidney disease: patient attitudes and expectations. J Ren Care (2014) 0.90
Analytical quality goals for 25-vitamin D based on biological variation. J Clin Lab Anal (2011) 0.89
The factor structure of the Revised Illness Perception Questionnaire (IPQ-R) in end-stage renal disease patients. Psychol Health Med (2012) 0.89
Summary of the 5th edition of the Renal Association Clinical Practice Guidelines (2009-2012). Nephron Clin Pract (2011) 0.88
UK Renal Registry 12th Annual Report (December 2009): chapter 10: biochemistry profile of patients receiving dialysis in the UK in 2008: national and centre-specific analyses. Nephron Clin Pract (2010) 0.88
Distinct depression symptom trajectories over the first year of dialysis: associations with illness perceptions. Ann Behav Med (2013) 0.88
Spinal cord infarction following central-line insertion. Ren Fail (2003) 0.88
Communication as care at end of life: an emerging issue from an exploratory action research study of renal end-of-life care for ethnic minorities in the UK. J Ren Care (2014) 0.87
The relationship between systemic and whole-body hematocrit is not constant during ultrafiltration on hemodialysis. J Am Soc Nephrol (2004) 0.86
Depression in end-stage renal disease: current advances and research. Semin Dial (2009) 0.86
Antimycin A induced cardioprotection is dependent on pre-ischemic p38-MAPK activation but independent of MKK3. J Mol Cell Cardiol (2005) 0.85
Children's physical activity assessed with wrist- and hip-worn accelerometers. Med Sci Sports Exerc (2014) 0.85
How robust is the 'surprise question' in predicting short-term mortality risk in haemodialysis patients? Nephron Clin Pract (2013) 0.84
Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia. Radiology (2012) 0.84
Are low erythropoietin and 1,25-dihydroxyvitamin D levels indicative of tubulo-interstitial dysfunction in diabetes without persistent microalbuminuria? Diabetes Res Clin Pract (2009) 0.84
Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function. Diabetes Res Clin Pract (2012) 0.83
Energy metabolism, body composition, and urea generation rate in hemodialysis patients. Hemodial Int (2013) 0.83
Linear decay of relative blood volume during ultrafiltration predicts hemodynamic instability. Am J Kidney Dis (2002) 0.83
Exploring the views of patients not on the transplant waiting list: a qualitative study. J Ren Care (2013) 0.82
Endotoxemia in end-stage kidney disease. Semin Dial (2014) 0.82
A self-report comorbidity questionnaire for haemodialysis patients. BMC Nephrol (2014) 0.82
Lack of awareness of kidney complications despite familiarity with diabetes: a multi-ethnic qualitative study. J Ren Care (2011) 0.82
Novel oral anticoagulants in acute coronary syndrome. Int J Cardiol (2012) 0.82
Waldenstrom's macroglobulinemia presenting as Goodpasture's syndrome. Ren Fail (2004) 0.81
Ablation of difficult right-sided accessory pathways aided by mapping of tricuspid annular activation using a Halo catheter : Halo-mapping of right sided accessory pathways. J Interv Card Electrophysiol (2006) 0.81
Human uraemic serum displays calcific potential in vitro that increases with advancing chronic kidney disease. Clin Sci (Lond) (2013) 0.81
Primary colorectal cancer: use of kinetic modeling of dynamic contrast-enhanced CT data to predict clinical outcome. Radiology (2013) 0.81
A confirmatory factor analysis of the Beck Depression Inventory-II in end-stage renal disease patients. J Psychosom Res (2011) 0.81
A dramatic reduction of normalized protein catabolic rate occurs late in the course of progressive renal insufficiency. Nephrol Dial Transplant (2005) 0.81
UK National Survey of Practice Patterns of Fluid Volume Management in Haemodialysis Patients: A Need for Evidence. Blood Purif (2016) 0.80
Illness representations and concurrent depression symptoms in haemodialysis patients. J Health Psychol (2011) 0.80
Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation. J Mol Cell Cardiol (2003) 0.80
Choosing not to take phosphate binders: the role of dialysis patients' medication beliefs. Nephron Clin Pract (2011) 0.80
Infective spondylodiscitis in patients on high-flux hemodialysis and on-line hemodiafiltration. Hemodial Int (2008) 0.79
Identifying depression in South asian patients with end-stage renal disease: considerations for practice. Nephron Extra (2011) 0.79
Predictors of recurrent hyperparathyroidism after total parathyroidectomy in chronic renal failure. Nephron Clin Pract (2003) 0.79
Isolated granulocytic sarcoma involving the mediastinum and bilateral cervical lymph nodes. Eur J Haematol (2007) 0.78
Dialysis amyloid: the bottom line. Nephrol Dial Transplant (2005) 0.78
Determinants of left ventricular hypertrophy and its progression in high-flux haemodialysis. Blood Purif (2003) 0.78
Temporary transvenous pacing: endangered skill. Emerg Med J (2011) 0.78
Evidence that self-affirmation improves phosphate control in hemodialysis patients: a pilot cluster randomized controlled trial. Ann Behav Med (2014) 0.78
Switching from subcutaneous to intravenous erythropoietin alpha in haemodialysis patients requires a major dose increase. Nephrol Dial Transplant (2005) 0.78
A multi-centre qualitative study exploring the experiences of UK South Asian and white diabetic patients referred for renal care. BMC Nephrol (2012) 0.78
Dalteparin dosing in high-flux haemodialysis and haemodiafiltration. Nephron Clin Pract (2013) 0.77
Haemodynamic effects of food intake during haemodialysis. Blood Purif (2008) 0.77
Integrated (18)F-FDG PET/CT and perfusion CT of primary colorectal cancer: effect of inter- and intraobserver agreement on metabolic-vascular parameters. AJR Am J Roentgenol (2012) 0.77
UK Renal Registry 13th Annual Report (December 2010): Chapter 11: blood pressure profile of prevalent patients receiving renal replacement therapy in England, Wales and Northern Ireland in 2009: national and centre-specific analyses. Nephron Clin Pract (2011) 0.77
Sleep apnoea in end-stage renal disease: a short review of mechanisms and potential benefit from its treatment. Nephrol Dial Transplant (2006) 0.77
Harnessing the microcirculation to increase dialysis efficiency. Nephron (2002) 0.77
T-cell subpopulations αβ and γδ in cord blood of very preterm infants: the influence of intrauterine infection. Arch Immunol Ther Exp (Warsz) (2013) 0.77